Larimar stock is down over 50% this year due to anaphylactic reactions in a study, rising expenses, and cautious market sentiment. Read why LRMR stock is a hold.

BALA CYNWYD, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...

Rare gemstones like Alexandrite, Tanzanite, Larimar, and Benitoite offer unique beauty and properties. Alexandrite changes ...

In a report released yesterday, Samantha Semenkow from Citi maintained a Buy rating on Catalyst Pharma (CPRX – Research Report), with a price ...

BALA CYNWYD, Pa. (AP) — BALA CYNWYD, Pa. (AP) — Larimar Therapeutics, Inc. (LRMR) on Monday reported a loss of $28.8 million in its fourth quarter. The Bala Cynwyd, Pennsylvania-based company ...

Captain Marek Harjak and his crew aboard the yacht Larimar became the first Estonians to participate in and complete the ...

Each zodiac sign is matched with a specific crystal that represents its unique traits. From the fiery spirit of Aries with ...

LARIMAR' Discovery Drive, FUNNEL BAY, Flametree is a 4 bedroom house. What are the key property features of 'LARIMAR' Discovery Drive, FUNNEL BAY, Flametree? Explore all key property features for ...

Ditch those notions of complimentary water bottles and tiny toiletry bags. These six hotels have stepped up the amenities ...

Larimar Therapeutics, Inc. (NASDAQ:LRMR), a clinical-stage pharmaceutical company with a market capitalization of $221 million, has issued performance-based restricted stock units (PSUs ...

The latest price target for Larimar Therapeutics (NASDAQ:LRMR) was reported by Guggenheim on March 25, 2025. The analyst firm set a price target for $26.00 expecting LRMR to rise to within 12 ...

BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) recently presented encouraging data from its studies on nomlabofusp at the International Congress for Ataxia Research in London.